Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ernexa Therapeutics Inc.NTN · Entity 8278 | Director | November 26, 2019 | November 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ernexa Therapeutics Inc.
Report date November 26, 2019 · Filed November 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy the Gottlieb Family Trust | 18,986 |
Reported balance
Holding disclosure · report date 2019-11-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 18,986 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Nov 27, 2019 13:30 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | GrantStock Options (Right to Buy) · Derivative | 600 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001493152-19-018469 · ownership.xml · derivative · entry 1 Gottlieb Michael · CIK 0001795170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2029-11-25 F1 · derivative.exercise_date: Stock option granted under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. This option shall vest and become exercisable at the rate of 50% of the total number of shares covered by this option immediately upon the date of grant. The remaining 50% of the total number of shares covered by this option shall vest and become exercisable in 12 equal monthly installments beginning in the month immediately following the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.